Digital Health

Screenshots of the Woebot app adapted for substance use

Image courtesy of Woebot Health

By  Dave Muoio 01:50 pm March 24, 2021
A recent study published in the Journal of Medical Internet Research (JMIR) shows initial support for a new version of Woebot – a text-based chatbot app designed to address mental health issues – that is designed to reduce substance use and other measures tied to substance use disorder (SUD). Conducted by researchers from Stanford University School of Medicine and Woebot Health, the investigation...
Fitbit Sleep

(Screenshot: Fitbit website) 

By  Laura Lovett 01:48 pm March 24, 2021
Sleep increased and bedtimes were later during the early months of the coronavirus pandemic, according to a study published in Sleep Health, which analyzed Fitbit data during the spring of 2020. The study zeroed in on Fitbit user data across six major U.S. cities to gain insights about the impact of the pandemic on participants' bedtime and sleep duration during the early days of the pandemic. "...
Three screens of Ro's app-based Roman offering

Image courtesy of Ro

By  Dave Muoio 12:38 pm March 23, 2021
Direct-to-consumer virtual care and mail-order prescription startup Ro is adding to its already impressive fundraising haul with a fresh $500 million investment headed by prior backers General Catalyst, FirstMark Capital and TQ Ventures, the company announced this morning. SignalFire Torch and BoxGroup also returned to participate in the Series D round, as did new investors Altimeter, Baupost,...
By  Anna Engberg 11:41 am March 18, 2021
A recent document released by the German Federal Institute for Drugs and Medical Devices (BfArM) has revealed that despite the invalidated Privacy Shield there are exemptions in place for Germany to allow data storage from digital health applications, so-called DiGAs, in European and even US clouds under specific terms. MobiHealthNews has looked into what it means for DiGA developers and startups...

(Photo by MR.Cole_Photographer/Getty Images)

By  Dave Muoio 03:07 pm March 17, 2021
AI isn't ready for COVID-19 prime time. A systematic review of published this week in nature machine intelligence warns that new models using machine learning to review chest radiographs and chest computed tomographies for COVID-19 have major methodical deficiencies or underlying biases. Among the 62 published or pre-print papers outlining these approaches, the authors wrote that not a single one...
Care team reviewing brain scan

(Photo by Tom Werner/Getty Images)

By  Mallory Hackett 11:54 am March 17, 2021
Today, an artificial intelligence care coordination company, shared the closing of its Series C funding round worth $71 million. Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures. This latest round comes about a year and a half after its $50 million Series B raise...
Happify Health's health and wellness app

Image courtesy of Happify Health

By  Dave Muoio 11:40 am March 17, 2021
Happify Health, a platform for mental health and disease management programs, has brought in $73 million in funding as part of a new Series D and other "related financing." Deerfield Management Company headed the investments, which also included funds from Omega Capital Partners, ION Crossover Partners and other prior backers. WHAT IT DOES Founded in 2012, Happify is best known for digital...
By  Sara Mageit 06:58 am March 17, 2021
A service allowing national apps to talk to each other has been set up by the European Commission, allowing users to receive a warning if they were in contact with someone who has indicated that they have tested positive for COVID-19.  Adopted by the majority of the Member States, the service works according to a “decentralised” system where the calculations happen in the user’s app. In...
Images of the Glooko app and a family

(Image: Screenshot of the website)

By  Dave Muoio 03:04 pm March 16, 2021
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise. WHAT IT DOES The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...